RHOQ antisense RNA 1 (RHOQ-AS1)

RHOQ antisense RNA 1 (RHOQ-AS1) is a long non-coding RNA transcribed in the antisense orientation relative to the RHOQ gene. Its presumed primary function is the regulation of the RHOQ gene through antisense mechanisms, which may involve modulation of RHOQ expression at the transcriptional or posttranscriptional level[2][4]. Antisense RNAs in general may bind to mRNAs produced from their complementary sense gene, affecting their stability, translation, or chromatin state[1][4]. While antisense RNAs have been implicated in various biological processes and diseases (notably as regulators and sometimes oncogenic or tumor suppressive RNAs), there is no published literature to date directly connecting RHOQ-AS1 to any specific pathology, biomarker status, drug interaction, or safety concern. Key details: - RHOQ-AS1 is an **antisense long non-coding RNA**, not a protein, receptor, or classic therapeutic target[2]. - Its function is presumed based on typical roles of antisense RNAs, such as modulating expression of a neighboring sense gene, in this case, *RHOQ* (also known as *ras homolog family member Q*)[2][1][4]. - There is no evidence in the literature that it is drug-targeted, nor that it plays a defined role in disease (e.g., cancer, inflammation, neurodegeneration) at this time. - RHOQ, the sense gene, is a small GTPase with roles in cytoskeletal reorganization and cell migration, and has been studied in cancer for effects of mRNA editing[3]; however, **RHOQ-AS1’s involvement in these processes is not demonstrated** in current publications[2][3].

Other names

RHOQ-AS1RHOQ AS1

Not a therapeutic target; mechanisms relate to antisense RNA regulation of the paired gene (RHOQ) via transcriptional or posttranscriptional modulation[1][4].